Can I Take Magnesium with Oral Micronized Progesterone (Prometrium)?

Direct answer

Magnesium and oral micronized progesterone (Prometrium, generic name progesterone USP, a bioidentical progestogen distinct from synthetic progestins such as medroxyprogesterone acetate) do not share a known drug-nutrient interaction pathway. Prometrium is cleared largely through hepatic CYP3A4 metabolism, and the FDA label's drug interaction section addresses CYP3A4 inducers and inhibitors, not minerals. Magnesium's own absorption and excretion are governed by intestinal transport channels and renal handling that are not altered by progesterone in any mechanism currently described in the literature. The open clinical question is not whether the two interact directly, but whether a woman on hormone therapy has other reasons, such as a diuretic or proton pump inhibitor, to be short on magnesium in the first place.

What is established, what is plausible, and what is not known

Why this question comes up in practice

Women starting hormone therapy are frequently also taking a proton pump inhibitor for reflux or a thiazide diuretic for blood pressure. Both drug classes are well documented, independent of progesterone, to reduce magnesium absorption or increase its renal loss. When magnesium is already borderline because of those other medications, adding Prometrium does not create a new mechanism of depletion, but it does mean the patient's total medication list, not the hormone alone, should guide the decision to check a magnesium level.

Progesterone's own relationship to magnesium is less settled. There is a physiologic argument, based on general steroid receptor biology in the kidney, that progesterone could influence electrolyte handling, but no controlled human study in women taking therapeutic-dose Prometrium has confirmed a clinically meaningful effect in either direction. Framing the combination as "progesterone depletes magnesium" overstates the evidence. Framing it as "the two do not interact" is closer to accurate but should be paired with a review of everything else on the patient's medication list.

Pharmacokinetics: why a direct interaction is mechanistically unlikely

Prometrium is dissolved in a peanut-oil suspension to improve bioavailability, and it undergoes substantial first-pass hepatic metabolism, producing neuroactive metabolites such as allopregnanolone that contribute to its sedating effect. Magnesium is absorbed in the small intestine through a saturable transcellular channel pathway and a passive paracellular route; absorption efficiency depends heavily on the salt form and the amount ingested at one time, per the NIH Office of Dietary Supplements fact sheet on magnesium.

Some divalent cations, including magnesium, are known to bind and reduce the absorption of specific oral medications, most notably tetracyclines, fluoroquinolones, and levothyroxine, when taken close together. That chelation mechanism depends on the drug having polar functional groups available for cation binding. Progesterone is a lipid-soluble steroid delivered in an oil suspension, not a polar small molecule of that type, so the same chelation concern does not transfer to Prometrium. This is a reasonable mechanistic inference rather than a claim backed by a dedicated interaction study, and it should be described to patients that way.

Should the doses be separated?

Prometrium's prescribing information recommends bedtime dosing with food, which most patients find pairs naturally with an evening magnesium supplement. No published interaction study has shown reduced Prometrium absorption when taken together with magnesium, so there is no established requirement to separate the two. A one to two hour separation is a reasonable, low-cost accommodation if a patient reports gastrointestinal discomfort when taking both at once, but it is a comfort measure rather than a pharmacokinetic necessity.

One real timing interaction does exist in this general medication landscape: magnesium can reduce the absorption of oral levothyroxine when taken together. Patients on thyroid hormone should keep their usual four-hour separation from magnesium regardless of when they take Prometrium.

Shared physiologic territory: sleep, glucose, and vascular tone

Progesterone's allopregnanolone metabolite modulates GABA-A receptors, contributing to the drowsiness many women notice with Prometrium. Magnesium is also described as supporting GABAergic signaling and blocking NMDA receptor activity, and small trials in older adults have reported subjective sleep benefits from magnesium supplementation, though the exact trial data behind any specific effect size need to be verified before being quoted to a patient as a fixed number. The plausible additive effect is drowsiness, which most women taking both agents at bedtime consider a benefit rather than a problem, but anyone who drives shortly after dosing should judge their own response first.

Magnesium deficiency is independently associated with impaired insulin sensitivity in the general nutrition literature, and progesterone at high concentrations has some described association with modest insulin resistance, though the effect at Prometrium's therapeutic dose is generally considered small relative to synthetic progestins. Ensuring adequate magnesium intake is a reasonable general health measure for women with metabolic risk factors starting HRT, but it should not be framed as correcting a progesterone-specific problem.

Magnesium acts as a physiologic calcium-channel antagonist and progesterone has vasodilatory actions in some vascular beds through separate mechanisms. Additive vasodilation at standard supplemental magnesium doses (200 to 400 mg/day elemental) is unlikely to be clinically significant in an otherwise healthy postmenopausal woman, but anyone with baseline low blood pressure should mention both to their prescriber.

Who should get a magnesium level checked before supplementing

Not every woman starting Prometrium needs a magnesium supplement or a baseline lab. A practical triage:

Lower concern, no routine testing needed. Prometrium alone, no diuretic or proton pump inhibitor, adequate dietary magnesium intake, no malabsorption condition.

Consider empiric supplementation without mandatory testing first. Prometrium plus a proton pump inhibitor, type 2 diabetes (associated with urinary magnesium wasting in general nephrology literature), or dietary intake well below the recommended dietary allowance.

Check serum magnesium before and during supplementation. Prometrium plus a loop or thiazide diuretic, confirmed prior hypomagnesemia, or chronic kidney disease stage 3b or higher.

Serum magnesium below roughly 0.75 mmol/L is generally used as the laboratory threshold for hypomagnesemia, though serum levels reflect only a small fraction of total body magnesium stores, so a normal result does not fully rule out tissue depletion in someone on long-term diuretic therapy. This caveat is worth discussing explicitly with patients who receive a "normal" lab value but still report symptoms.

When symptoms could be magnesium, not progesterone

Hypomagnesemia is often silent until levels fall further, at which point muscle cramps, palpitations, and anxiety can appear. Those same symptoms are commonly attributed to progesterone side effects or estrogen fluctuation in women on HRT, which can make the clinical picture confusing. National dietary survey data have repeatedly shown that a substantial share of U.S. adults, including postmenopausal women, consume less magnesium than the estimated average requirement. When a patient develops new cramps, sleep disruption, or palpitations after starting Prometrium, a reasonable step is to review the full medication list, including any diuretic or proton pump inhibitor, before assuming the hormone is the cause.

Choosing a magnesium form

• Glycinate. Generally well tolerated with minimal gastrointestinal effect; a common first choice for sleep support.
• Citrate. Well absorbed; has a mild osmotic laxative effect at higher doses, which some women find useful given that constipation is a recognized side effect of Prometrium.
• Oxide. Inexpensive but poorly absorbed relative to citrate or glycinate; not a preferred choice when correcting a documented deficiency.
• L-threonate. Marketed for cognitive support based on animal data; human trial evidence in postmenopausal women is limited, and it costs considerably more per milligram of elemental magnesium.

The NIH Office of Dietary Supplements sets the tolerable upper intake level for supplemental (non-food) elemental magnesium at 350 mg/day for adults, primarily to avoid osmotic diarrhea. This ceiling applies to supplement and medication sources, not to magnesium from food.

A checklist to bring to a prescriber or pharmacist

1. List every current medication, including proton pump inhibitors, diuretics, thyroid hormone, and antibiotics.
2. Note any current symptoms: cramps, insomnia, anxiety, constipation, palpitations.
3. Estimate dietary magnesium intake (nuts, seeds, legumes, and whole grains are common sources).
4. Prefer magnesium glycinate or citrate over oxide for supplementation.
5. Confirm whether a baseline serum magnesium check is warranted given the diuretic/PPI/diabetes criteria above.
6. Take magnesium at the same time as Prometrium unless gastrointestinal discomfort prompts a one to two hour separation.
7. Keep any levothyroxine dose at least four hours from magnesium, regardless of Prometrium timing.
8. Report new muscle weakness, significant diarrhea, or palpitations to the prescribing clinician promptly.

Evidence boundary

What is established: magnesium is absent from Prometrium's FDA-listed interactions, the two are metabolized through unrelated pathways, and known magnesium-depleting drug classes (proton pump inhibitors, certain diuretics) are common co-medications in this population. What is mechanistically plausible but not confirmed in trials of women taking therapeutic-dose Prometrium: additive sedation, a modest favorable effect of adequate magnesium on insulin sensitivity in women with metabolic risk, and a renal receptor-mediated effect of progesterone on magnesium handling. What is not established: any measurable effect of magnesium supplementation on serum progesterone concentration, or a documented case of clinically significant magnesium depletion caused by progesterone alone at labeled doses. Readers should not extrapolate general magnesium-drug interaction rules (such as the chelation seen with tetracyclines) onto progesterone, since the chemistry does not transfer.